WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New DDDs

List of new DDDs decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the DDDs should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new DDDs will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

ATC codeATC level name (INN/generic name)DDDUnitAdm.routeDeadline for objection to temporary DDDs Implementation in ATC/DDD index if no objection is received
A10BX11canagliflozin0.2gO01.02.20152016
A10BX13albiglutide5.7mgP01.02.20152016
C02KX05riociguat4.5mgO01.02.20152016
C09CA09azilsartan medoxomil40mgO01.02.20152016
C10AX12lomitapide40mgO01.02.20152016
G02AD06misoprostol0.2mgV 1)01.02.20152016
J05AE14simeprevir0.15gO01.02.20152016
J05AX14daclatasvir60mgO01.02.20152016
L02BX01abarelix3.6mgP01.02.20152016
L03AB13peginterferon beta-1a8.9mcgP01.02.20152016
L04AA33vedolizumab5.4mgP01.02.20152016
L04AC11siltuximab37mgP01.02.20152016
N05AH01loxapine9.1mginhal powder 2)01.02.20152016
N05AX12aripiprazole13.3mgP depot01.02.20152016
N06BA11dexmethylphenidate15mgO01.02.20152016
R03AC19olodaterol5mcginhal sol01.02.20152016
V03AE05sucroferric oxyhydroxide1.5gO01.02.20152016
V03AX03cobicistat0.15gO01.02.20152016
1) vaginal insert, refert to the content of one vaginal insert
2) delivered dose

Last updated: 2014-12-09